Research Overview
Nontuberculous mycobacteria (NTM) are resistant to various antibiotics, and NTM infections are generally difficult to treat. Therefore, we are evaluating the efficacy of new and existing antimicrobial agents against NTM and exploring effective treatments for NTM infections.
Key Research Achievements
*Corresponding Author
- Misawa K, Nishimura T*, Kashimura S, Enoki Y, Taguchi K, Uno S, Uwamino Y, Matsumoto K, Hasegawa N. In vitro effects of diazabicyclooctane β-lactamase inhibitors relebactam and nacubactam against three subspecies of Mycobacterium abscessus complex. Int J Antimicrob Agents. 2022; 60(5-6): 106669. doi: 10.1016/j.ijantimicag.2022.106669.